GC Biopharma Corp

Active trials

• phase3A Study to Evaluate Immunogenicity and Safety After the First and Second Doses of MG1111 (BARYCELA Inj.) in Healthy Children Aged 12 Months to 12 Yearsrecruitingn=474
• phase3An Extension Study to Assess the Long-term Safety and Efficacy of Hunterase (Idursulfase Beta)completedn=30
• phase1A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patientcompletedn=15
• phase2A proof-of Concept Study to Assess Safety and Tolerability of HM15421/GC1134A in Patients With Fabry Diseaserecruitingn=18
• phase1Phase 1 Study of GC1130A in Patients With Sanfilippo Syndrome Type A (MPS IIIA)recruitingn=9
• phase3Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiencyactive not recruitingn=24
• —Evaluation of the Effectiveness and Safety of Rozetel Tablet in Patients After PCI: A Multi-Center Observational Studyactive not recruitingn=1,563
• phase2A Phase I/II Study to Evaluate the Safety and Immunogenicity of GC3111B in Healthy Adultsrecruitingn=120